4
Changes in Ownership
Design Therapeutics, Inc. Filed Acc 0001674703-26-000002
Options or other derivatives
- Chief Medical Officer acquired 250,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Storgard Chris · Chief Medical Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-02 | Grant or award : show line 1 in the form Stock option (right to buy) | +250,000 | 250,000 | D |
Loading xslF345X05/form4-01052026_090112.xml…